ExploreInterventionCNS-directed chemotherapy
Intervention

CNS-directed chemotherapy

Also known as: Contemporary CNS-directed chemotherapy for pediatric ALL (protocols AALL0434, AALL0932, AALL1131, AALL1231, without cranial radiation or bone marrow transplant)
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
outcomes
populations
studys

Findings (27)

None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49

Papers (1)